Expert panel of the Drug Controller General of India (DCGI) has recommended granting emergency use authorisation for Corbevax for children in the 5 to 12 years age group.
The Union Cabinet chaired by Prime Minister Shri Narendra Modi has approved the continuation of the Atal Innovation Mission (AIM) for a further period till March 2023.